Bioncotech Therapeutics S.L logo

Bioncotech Therapeutics S.L

Development stage biopharma company. Innovative therapies for cancer. Spin-off from Spain's National Cancer Research Center (CNIO) Bioncotech Therapeutics (spin-off from the Spanish National Cancer Research Centre), is a biotechnology company developing cutting-edge RNA-based therapies against validated and novel targets in cancer and immune cells.

Bioncotech is a VC-funded, clinical-stage, immune-oncology company with offices in Madrid and Valencia in Spain. DROIA Oncology Ventures is the key investor in the company.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.bioncotech.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
C/ Catedratico Agustin Escardino, 9, Parc Cientific Universitat,Paterna, 46980
Valencia
Spain
Email
Contact Number
+34 96 1109955

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/bioncotech-therapeutics” connections=”true” suffix=””]

Bioncotech Therapeutics projects are financed with grants INNPACTO 2010 and INNCORPORA 2011 (two Torres Quevedo and two INNCORPORA University Graduates) to co-finance research personnel.